PE-backed Clario picks up medical research biz NeuroRx

Clario's controlling shareholders are Astorg, Nordic Capital, Novo Holdings, and Cinven.

17 March 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.